Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs Sirolimus + Prednisolone for KHE With KMP
NCT03188068Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in kaposiform hemangioendothelioma (KHE), Kasabach-Merritt phenomenon (KMS), sponsored by West China Hospital of Sichuan University. Started Jun 2017; status: completed.
02
Drugs
sirolimus
03
Conditions
kaposiform hemangioendothelioma (KHE)Kasabach-Merritt phenomenon (KMS)
Beyond the preview
Go deeper on NCT03188068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188068.